Evidence map›Paper›PMID 33615903›Full record

ArticleAIDS care2022

PrEP eligibility, HIV risk perception, and willingness to use PrEP among high-risk men who have sex with men in India: A cross-sectional survey.

Venkatesan Chakrapani, Peter A Newman, Murali Shunmugam, Shruta Rawat, Dicky Baruah, Ruban Nelson, Surachet Roungkraphon, Suchon Tepjan

Abstract read
In one paragraph

Article in AIDS care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Venkatesan ChakrapaniCentre for Sexuality and Health Research and Policy (C-SHaRP), Chennai, India.ORCID 0000-0001-9998-9135
Peter A NewmanFactor-Inwentash Faculty of Social Work, University of Toronto, Toronto, Canada.ORCID 0000-0003-0444-5915
Murali ShunmugamCentre for Sexuality and Health Research and Policy (C-SHaRP), Chennai, India.ORCID 0000-0002-8852-6810
Shruta RawatThe Humsafar Trust, Mumbai, India.
Dicky BaruahThe Humsafar Trust, Mumbai, India.
Ruban NelsonCentre for Sexuality and Health Research and Policy (C-SHaRP), Chennai, India.
Surachet RoungkraphonFaculty of Science and Technology, Rajamangala University of Technology Phra Nakhon, Bangkok, Thailand.
Suchon TepjanVOICES-Thailand Foundation, Chiang Mai, Thailand.

Funding

CIHR MOP-102512CIHR THA-118570DBT-Wellcome Trust India Alliance IA/CPHS/16/1/502667Wellcome Trust
6 · The paper itself

Abstract

HIV pre-exposure prophylaxis (PrEP) is not yet included in India's national AIDS program, with demonstration projects for MSM in planning stages. In order to support PrEP roll-out for MSM, we assessed: (1) associations between guideline-informed PrEP eligibility, HIV risk perception, and perceived PrEP benefits and costs, with willingness to use PrEP (WTUP); and (2) correlates of non-WTUP among PrEP-eligible MSM. Data were collected from MSM (

Indexed as

HIV InfectionsSexual and Gender MinoritiesCross-Sectional StudiesHomosexuality, MaleHumansIndiaMalePerceptionHIV preventionIndiaMSMperceived riskpre-exposure prophylaxis

Identifiers

PMID33615903
PMCPMC7612569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.